Corcept Therapeutics Inc
NASDAQ:CORT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Corcept Therapeutics Inc
NASDAQ:CORT
|
US |
|
Spire Global Inc
F:EL9
|
US |
|
S
|
Standard Chartered PLC
XMUN:STD
|
UK |
Wall St Price Targets
CORT Price Targets Summary
Corcept Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for CORT is 89.76 USD with a low forecast of 50.5 USD and a high forecast of 141.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CORT's stock price target?
Price Target
89.76
USD
According to Wall Street analysts, the average 1-year price target for CORT is 89.76 USD with a low forecast of 50.5 USD and a high forecast of 141.75 USD.
What is the Revenue forecast for Corcept Therapeutics Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Revenue has been 52%. The projected CAGR for the next 8 years is 20%.
What is the Gross Profit forecast for Corcept Therapeutics Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 52%. The projected CAGR for the next 8 years is 20%.
What is the Operating Income forecast for Corcept Therapeutics Inc?
Projected CAGR
65%
The compound annual growth rate for Operating Income over the next 8 years is 65%.
What is the Pre-Tax Income forecast for Corcept Therapeutics Inc?
Projected CAGR
108%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 108%.
What is the Net Income forecast for Corcept Therapeutics Inc?
Projected CAGR
46%
The compound annual growth rate for Net Income over the next 8 years is 46%.
